STAND. COM. REP. NO.  1207-18

 

Honolulu, Hawaii

                , 2018

 

RE:   S.B. No. 2646

      S.D. 1

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

 

Sir:

 

     Your Committee on Health & Human Services, to which was referred S.B. No. 2646, S.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"

 

begs leave to report as follows:

 

     The purpose of this measure is to require prescribers to consult the State Electronic Prescription Accountability System before issuing a prescription for certain controlled substances.

 

     The Department of Health, Department of Public Safety, and Hawaii Medical Service Association supported this measure.  The Hawaii Medical Association, Hawaii Society of Clinical Oncology, and The Drug Policy Forum of Hawaii provided comments.

 

     Your Committee has amended this measure by:

 

     (1)  Requiring prescribers to consult the State Electronic Prescription Accountability System before issuing a prescription for a duration of seven days or more;

 

     (2)  Exempting any prescription for post-surgical care, provided that a patient who is prescribed a prescription for a duration of seven days or more shall be informed of the risks and harms of opioid addiction;

     (3)  Including that a violation of the provisions in this measure may result in disciplinary action under sections 448-17 and 471-10, Hawaii Revised Statutes;

 

     (4)  Appropriating funds to improve the functionality and reliability of the State Electronic Prescription Accountability System; and

 

     (5)  Making technical, nonsubstantive amendments for clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Health & Human Services that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2646, S.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2646, S.D. 1, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.

 

 

Respectfully submitted on behalf of the members of the Committee on Health & Human Services,

 

 

 

 

____________________________

JOHN M. MIZUNO, Chair